TransSCOT is the translational arm of the SCOT trial, an “international, randomised, phase 3, non-inferiority trial” involving adult patients with high-risk stage II or stage III colorectal cancer.
The TransSCOT project aims to support collaborators with CRC research. We will do this by:
- Managing a large tissue bank of tumour resections and matched normal FFPE blocks from over 3,000 patients from the SCOT trial (Glasgow).
- Managing a large blood bank of the same patients (serum and EDTA) (Oxford)
- Constructing a biobank of tissue microarrays containing tumour centre and invasive edge from the SCOT tissue blocks for use in future projects
- Extracting DNA and RNA for sequencing and future projects
- Building a large bank of digital images for data sharing, IA and AI analysis
- Building a comprehensive database of anonymised information for data mining projects, including, but not limited to: anonymised linked clinical data, anonymised pathology data, anonymised genomic and transcriptomics data, shared outputs and results from collaborators to build upon existing research.